TY  - JOUR

T1  - Pharmacokinetics (PK) and safety of tralokinumab in children (aged 6 to <12 years) with moderate-to-severe atopic dermatitis: an interim analysis of the TRAPEDS 1 phase 2 trial

JO  - Journal of Investigative Dermatology

UR  - https://doi.org/10.1016/s0022-202x(26)00604-4

PY  - 2026/03/01

AU  - Cork M

AU  - de Graaf M

AU  - Torres EB

AU  - Pasmans S

AU  - Reguiai Z

AU  - Kurvits M

AU  - Lo H

AU  - Schneider S

AU  - Søhoel A

AU  - Thøgersen P

AU  - Flohr C et al

ED  - 

DO  - DOI: 10.1016/s0022-202x(26)00604-4

PB  - Elsevier BV

VL  - 146

IS  - 3

SP  - S17

EP  - S17

Y2  - 2026/03/16

ER  -